Clinical results of resection of soft tissue sarcoma of the distal lower leg

Clinical outcomes of soft tissue sarcoma (STS) of the distal lower leg remain poorly characterized. We investigated the oncological and functional outcomes of it. We retrospectively reviewed 42 patients with distal lower leg STS who underwent surgery between 1996 and 2021. Functional outcomes were assessed by Musculoskeletal Tumor Society (MSTS) score, and oncological outcomes included local recurrence-free survival (LRFS), metastasis-free survival (MFS), and overall survival (OS). The median MSTS score was 26.5. In unadjusted comparisons, age ≥ 65 years, tumor size > 5 cm, bone reconstruction, and major nerve resection were associated with poorer function. Patients who underwent tendon reconstruction had MSTS scores and walking-support rates comparable to those of patients without tendon resection. The 5-year LRFS, MFS, and OS rates were 86%, 69%, and 73%, respectively. Tumor size > 5 cm was the only predictor of worse OS. Tendon reconstruction was associated with preserved postoperative function, whereas bone reconstruction was associated with lower functional scores in this cohort. Patients with larger tumor size (> 5 cm) need careful follow-up.

Authors

Institutions

Publication Details

Journal
European Journal of Orthopaedic Surgery & Traumatology
Published
2026-11-19
DOI
https://doi.org/10.1007/s00590-026-05015-2
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical results of resection of soft tissue sarcoma of the distal lower leg

Toshifumi Ozaki, Teruhiko Ando, Eiji Nakata, Toshiyuki Kunisada et al.
European Journal of Orthopaedic Surgery & Traumatology
Sarcoma Diagnosis and Treatment
article

Clinical results of resection of soft tissue sarcoma of the distal lower leg

Toshifumi Ozaki, Teruhiko Ando, Eiji Nakata, Toshiyuki Kunisada, Hiroya Kondo, Takahiko Ishimaru, Yoshimi Katayama, Hironori Tsuji, Takuto Itano, Ryuichi Nakahara, Masanori Hamada, Tomohiro Fujiwara
article en

Abstract

Clinical outcomes of soft tissue sarcoma (STS) of the distal lower leg remain poorly characterized. We investigated the oncological and functional outcomes of it. We retrospectively reviewed 42 patients with distal lower leg STS who underwent surgery between 1996 and 2021. Functional outcomes were assessed by Musculoskeletal Tumor Society (MSTS) score, and oncological outcomes included local recurrence-free survival (LRFS), metastasis-free survival (MFS), and overall survival (OS). The median MSTS score was 26.5. In unadjusted comparisons, age ≥ 65 years, tumor size > 5 cm, bone reconstruction, and major nerve resection were associated with poorer function. Patients who underwent tendon reconstruction had MSTS scores and walking-support rates comparable to those of patients without tendon resection. The 5-year LRFS, MFS, and OS rates were 86%, 69%, and 73%, respectively. Tumor size > 5 cm was the only predictor of worse OS. Tendon reconstruction was associated with preserved postoperative function, whereas bone reconstruction was associated with lower functional scores in this cohort. Patients with larger tumor size (> 5 cm) need careful follow-up.

European Journal of Orthopaedic Surgery & TraumatologyVol. 37(1)
Okayama University Hospital (JP), National Cancer Center Hospital (JP)
Sarcoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon